您的位置: 首页 > 农业专利 > 详情页

PEPTIDES MELK MODIFIÉS ET VACCINS ASSOCIÉS
专利权人:
ONCOTHERAPY SCIENCE; INC.
发明人:
NAKAMURA, YUSUKE,TSUNODA, TAKUYA,OHSAWA, RYUJI,YOSHIMURA, SACHIKO,WATANABE, TOMOHISA
申请号:
EP11734528
公开号:
EP2528937A4
申请日:
2011.01.24
申请国别(地区):
EP
年份:
2013
代理人:
摘要:
Isolated peptides composed of the amino acid sequence of the modified MELK epitope peptide or immunologically active fragments thereof that bind to HLA antigens and have higher cytotoxic T lymphocyte (CTL) inducibility than that of the wild type MELK epitope peptide and thus are suitable for use in the context of cancer immunotherapy or endometriosis immunotherapy, more particularly cancer or endometriosis vaccines are described herein. The present invention further provides peptides that include one, two, or several amino acid insertions, substitutions or additions to the aforementioned peptides or fragments, but yet retain the requisite cytotoxic T cell inducibility. Further provided are nucleic acids encoding any of these aforementioned peptides as well as pharmaceutical substances and compositions including any of the aforementioned peptides or nucleic acids. The peptides, nucleic acids, pharmaceutical substances and compositions of this invention find particular utility in the treatment of cancers, tumors, and endometriosis.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充